Calendrier des promotions Axcella Health Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Axcella Health Inc.
Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.Paramètres de base
IPO date
2019-05-09
ISIN
US05454B1052
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 0 | 0 |
P/BV | 0 | 0 |
P/E | 0 | 0 |
Efficacité
Nom | Signification | Grade |
ROA | 0 | 0 |
ROE | 0 | 0 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0 | 0 |
DSI | 0 | 0 |
Croissance moyenne du dividende | 0 | 0 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | 0 | 10 |
Debt/Ratio | 0 | 10 |
Debt/Equity | 0 | 10 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | 0 | 0 |
Rentabilité Ebitda, % | 91.45 | 9 |
Rentabilité EPS, % | -97.23 | 0 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 0.4009 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 0.4009 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.30d | 0.4009 $ | 0.4009 $ | 0.4009 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.90d | 0.4009 $ | 0.4009 $ | 0.4009 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.180d | 0.4009 $ | 0.4009 $ | 0.4009 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.1y | 0.4009 $ | 0.4009 $ | 4.58 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.3y | 2.45 $ | 0.11 $ | 375 $ | -83.64 % | 0 % | 0 % |
common.calendar.number_days.5y | 4.49 $ | 0.11 $ | 375 $ | -91.07 % | 0 % | 0 % |
common.calendar.number_days.10y | 0.11 $ | 0.11 $ | 375 $ | 364.45 % | 0 % | 0 % |
common.calendar.number_days.ytd | 0.4009 $ | 0.4009 $ | 0.4009 $ | 0 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Dr. Alison D. Schecter M.D. | Pres of Strategy & Operations | 525.53k | 1964 (61 année) |
Mr. David R. Epstein B.Sc., M.B.A. | Consultant | 228.34k | 1962 (63 année) |
Mr. Dan Kirby | Sr. VP of Strategic Operations | N/A | |
Mr. William R. Hinshaw Jr. | Pres, CEO & Director | 1969 (56 années) | |
Mr. Laurent Chardonnet | Consultant | 1965 (60 années) | |
Mr. Robert W. Crane | Sr. VP & CFO | 1959 (66 années) | |
Dr. Paul Fehlner J.D., Ph.D. | Sr. VP, Chief Legal Officer & Corp. Sec. | 1964 (61 année) | |
Ms. Virginia R. Dean | Sr. VP & Chief People Officer | 1966 (59 années) | |
Dr. Larry Bell | Global Head of Regulatory Affairs & Pharmacovigilance and Sr. VP | ||
Dr. Margaret James Koziel M.D. | Sr. VP & Chief Medical Officer | 1960 (65 années) |
Informations sur l'entreprise
Adresse: United States, Cambridge. MA, 840 Memorial Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.axcellahealth.com
Site web: https://www.axcellahealth.com